The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Antiemetic Drugs-Global Market Insights and Sales Trends 2024

Antiemetic Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1859099

No of Pages : 115

Ask Your Query
Synopsis
An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
The global Antiemetic Drugs market size is expected to reach US$ 6489.9 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Antiemetic Drugs in various end use industries. The expanding demands from the Chemotherapy, Gastroenteritis and Surgery,, are propelling Antiemetic Drugs market. Dopamine Antagonist, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 5-HT-3 Receptor Antagonist segment is estimated at % CAGR for the next seven-year period.
The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antiemetic Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antiemetic Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antiemetic Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antiemetic Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antiemetic Drugs covered in this report include GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai and Eli Lilly, etc.
The global Antiemetic Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Global Antiemetic Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antiemetic Drugs market, Segment by Type:
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Global Antiemetic Drugs market, by Application
Chemotherapy
Gastroenteritis
Surgery
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antiemetic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antiemetic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Antiemetic Drugs Market Overview
1.1 Antiemetic Drugs Product Overview
1.2 Antiemetic Drugs Market Segment by Type
1.2.1 Dopamine Antagonist
1.2.2 5-HT-3 Receptor Antagonist
1.2.3 NK1 Receptor Antagonist
1.2.4 Cannabinoid Receptor Antagonist
1.3 Global Antiemetic Drugs Market Size by Type
1.3.1 Global Antiemetic Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antiemetic Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antiemetic Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antiemetic Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antiemetic Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antiemetic Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antiemetic Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antiemetic Drugs Sales Breakdown by Type (2018-2023)
2 Global Antiemetic Drugs Market Competition by Company
2.1 Global Top Players by Antiemetic Drugs Sales (2018-2023)
2.2 Global Top Players by Antiemetic Drugs Revenue (2018-2023)
2.3 Global Top Players by Antiemetic Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antiemetic Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antiemetic Drugs Market Competitive Situation and Trends
2.5.1 Antiemetic Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antiemetic Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antiemetic Drugs Market
2.8 Key Manufacturers Antiemetic Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antiemetic Drugs Status and Outlook by Region
3.1 Global Antiemetic Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antiemetic Drugs Historic Market Size by Region
3.2.1 Global Antiemetic Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antiemetic Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antiemetic Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antiemetic Drugs Forecasted Market Size by Region
3.3.1 Global Antiemetic Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antiemetic Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antiemetic Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antiemetic Drugs by Application
4.1 Antiemetic Drugs Market Segment by Application
4.1.1 Chemotherapy
4.1.2 Gastroenteritis
4.1.3 Surgery
4.2 Global Antiemetic Drugs Market Size by Application
4.2.1 Global Antiemetic Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Antiemetic Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antiemetic Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antiemetic Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antiemetic Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antiemetic Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antiemetic Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antiemetic Drugs Sales Breakdown by Application (2018-2023)
5 North America Antiemetic Drugs by Country
5.1 North America Antiemetic Drugs Historic Market Size by Country
5.1.1 North America Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antiemetic Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antiemetic Drugs Sales in Value by Country (2018-2023)
5.2 North America Antiemetic Drugs Forecasted Market Size by Country
5.2.1 North America Antiemetic Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antiemetic Drugs Sales in Value by Country (2024-2029)
6 Europe Antiemetic Drugs by Country
6.1 Europe Antiemetic Drugs Historic Market Size by Country
6.1.1 Europe Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antiemetic Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antiemetic Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antiemetic Drugs Forecasted Market Size by Country
6.2.1 Europe Antiemetic Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antiemetic Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antiemetic Drugs by Region
7.1 Asia-Pacific Antiemetic Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antiemetic Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antiemetic Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antiemetic Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antiemetic Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antiemetic Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antiemetic Drugs Sales in Value by Region (2024-2029)
8 Latin America Antiemetic Drugs by Country
8.1 Latin America Antiemetic Drugs Historic Market Size by Country
8.1.1 Latin America Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antiemetic Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antiemetic Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antiemetic Drugs Forecasted Market Size by Country
8.2.1 Latin America Antiemetic Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antiemetic Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antiemetic Drugs by Country
9.1 Middle East and Africa Antiemetic Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antiemetic Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antiemetic Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antiemetic Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antiemetic Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antiemetic Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antiemetic Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Antiemetic Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Antiemetic Drugs Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Antiemetic Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Antiemetic Drugs Products Offered
10.4.5 Sanofi Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Antiemetic Drugs Products Offered
10.5.5 Abbott Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Company Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bristol-Myers Squibb Antiemetic Drugs Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Cipla
10.7.1 Cipla Company Information
10.7.2 Cipla Introduction and Business Overview
10.7.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cipla Antiemetic Drugs Products Offered
10.7.5 Cipla Recent Development
10.8 Eisai
10.8.1 Eisai Company Information
10.8.2 Eisai Introduction and Business Overview
10.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eisai Antiemetic Drugs Products Offered
10.8.5 Eisai Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eli Lilly Antiemetic Drugs Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Glenmark
10.10.1 Glenmark Company Information
10.10.2 Glenmark Introduction and Business Overview
10.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Glenmark Antiemetic Drugs Products Offered
10.10.5 Glenmark Recent Development
10.11 Helsinn Healthcare
10.11.1 Helsinn Healthcare Company Information
10.11.2 Helsinn Healthcare Introduction and Business Overview
10.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Helsinn Healthcare Antiemetic Drugs Products Offered
10.11.5 Helsinn Healthcare Recent Development
10.12 Heron Therapeutics
10.12.1 Heron Therapeutics Company Information
10.12.2 Heron Therapeutics Introduction and Business Overview
10.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Heron Therapeutics Antiemetic Drugs Products Offered
10.12.5 Heron Therapeutics Recent Development
10.13 IPCA Laboratories
10.13.1 IPCA Laboratories Company Information
10.13.2 IPCA Laboratories Introduction and Business Overview
10.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 IPCA Laboratories Antiemetic Drugs Products Offered
10.13.5 IPCA Laboratories Recent Development
10.14 Lupin
10.14.1 Lupin Company Information
10.14.2 Lupin Introduction and Business Overview
10.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Lupin Antiemetic Drugs Products Offered
10.14.5 Lupin Recent Development
10.15 Merck
10.15.1 Merck Company Information
10.15.2 Merck Introduction and Business Overview
10.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Merck Antiemetic Drugs Products Offered
10.15.5 Merck Recent Development
10.16 Novartis
10.16.1 Novartis Company Information
10.16.2 Novartis Introduction and Business Overview
10.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Novartis Antiemetic Drugs Products Offered
10.16.5 Novartis Recent Development
10.17 RedHill
10.17.1 RedHill Company Information
10.17.2 RedHill Introduction and Business Overview
10.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 RedHill Antiemetic Drugs Products Offered
10.17.5 RedHill Recent Development
10.18 Sun Pharmaceutical Industries
10.18.1 Sun Pharmaceutical Industries Company Information
10.18.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Products Offered
10.18.5 Sun Pharmaceutical Industries Recent Development
10.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Information
10.19.2 Takeda Pharmaceutical Introduction and Business Overview
10.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Takeda Pharmaceutical Antiemetic Drugs Products Offered
10.19.5 Takeda Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antiemetic Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antiemetic Drugs Industrial Chain Analysis
11.4 Antiemetic Drugs Market Dynamics
11.4.1 Antiemetic Drugs Industry Trends
11.4.2 Antiemetic Drugs Market Drivers
11.4.3 Antiemetic Drugs Market Challenges
11.4.4 Antiemetic Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antiemetic Drugs Distributors
12.3 Antiemetic Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock